Status:

UNKNOWN

Estimate of the TSD Based on the Quantification of the Tau Protein in CSF

Lead Sponsor:

University Hospital, Montpellier

Conditions:

Time of Death

Eligibility:

All Genders

18+ years

Brief Summary

Background: The accurate estimation of the time of death is a challenge in forensic medicine, as the methods routinely used to assess the post-mortem interval (PMI) are far from being precise. Recent ...

Detailed Description

Background: The accurate estimation of the time of death is a challenge in forensic medicine, as the methods routinely used to assess the post-mortem interval (PMI) are far from being precise. Recent ...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • \- Adult cadavers whose time of death is precisely known
  • Exclusion criteria:
  • \- Individuals with neurological disorders, head trauma or with unknown past medical history or cause of death

Exclusion

    Key Trial Info

    Start Date :

    November 1 2017

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 30 2019

    Estimated Enrollment :

    80 Patients enrolled

    Trial Details

    Trial ID

    NCT03845439

    Start Date

    November 1 2017

    End Date

    October 30 2019

    Last Update

    February 19 2019

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    PEYRON

    Montpellier, France, 34295